Partners Doreen Lilienfeld (New York–Compensation, Governance & ERISA), Co-Head of the Healthcare Industry Group and Global Head of the Governance & Advisory Group, and Lona Nallengara (New York–Capital Markets) spoke on the “IPOs and Public Companies – Current Issues & Legal Considerations” panel at the Nordic-American Life Science Conference hosted in our New York office.
Discussion topics included: